0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Fatal Candida Esophagitis in Two Diabetics After Renal Transplantation

Jeffrey M. Jones, MD, PhD; Neal R. Glass, MD; Folkert O. Beizer, MD
Arch Surg. 1982;117(4):499-501. doi:10.1001/archsurg.1982.01380280079016.
Text Size: A A A
Published online

• Severe necrotizing Candida esophagitis developed in two insulin-dependent diabetics after they received renal allografts. In each patient, the infection led to a perforation of the esophagus and was ultimately fatal despite aggressive medical and surgical management. The frequency and severity of Candida esophagitis seems to be higher in diabetics rather than in nondiabetic patients who receive renal transplants. In these two diabetic transplant recipients, small doses of oral nystatin did not prevent Candida esophagitis. Appropriate diagnostic tests must be performed promptly when symptoms of odynophagia or dysphagia develop in these patients. In diabetic transplant recipients with documented candidiasis, decreased symptoms of esophagitis should not be relied on to indicate a response to therapy. Discontinuation of immunosuppressive drugs, as well as aggressive treatment with oral and parenterally absorbed antifungal agents, offer the best hope for preventing severe morbidity or mortality from the infection in these patients.

(Arch Surg 1982;117:499-501)

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();